Longread

Global, Longread

2019: The Year in Cannabis

Cannabis Wire’s roundup and analysis of the top stories and trends in global cannabis business, policy, and research in 2019.

Longread

Cannabis Kingdom: High Hopes and Early Stumbles in Lesotho

This small African nation is ideal for growing cannabis, but maybe not for regulating it.

Longread

New Zealand: When It Comes to Cannabis, This Liberal Nation Is Not So Relaxed

Even though the government recently expanded medical access, its stance still seems far more conservative than the electorate’s.

Longread

History Repeating

Hemp is legal. Cannabis legalization is close behind. How did we get here? This 4/20, unwind with this excerpt from A New Leaf: The End of Cannabis Prohibition.

Enforcement, Longread

In ICE’s Arsenal: Cannabis Convictions

For immigrants, including those who came to the US legally, even a misdemeanor can trigger the harshest possible consequences.

Business, Congress, Lobbying, Longread

PART III: A Sea Change for Cannabis Politics

As legislative priorities shift, what is gained? And what is lost?

Business, Congress, Lobbying, Longread

PART II: The Cannabis Industry Learns to Play Politics

Cannabis companies are increasingly lobbying and handing out campaign contributions on both sides of the aisle.

Business, Congress, Lobbying, Longread

PART I: Cannabis Courts the Grand Old Party

The cannabis debate in Congress is being reshaped along GOP-friendly lines.

Business, Congress, Lobbying, Longread

Cannabis Goes To Washington

A burgeoning industry is using its money to influence politics, and finding new GOP allies in the process. But there may be a price.

Longread, Oregon

When Oregon Blew It

Weak cannabis regulation helped create a boom, and as it recedes the high costs are becoming clear.

Longread

The Prisoners Left Behind

How Barack Obama’s clemency operation failed thousands of drug offenders, some serving long sentences for cannabis crimes, and left them at the mercy of Donald Trump’s whims.

Longread

In Public Housing, a Cannabis Catch-22

Some federally subsidized tenants are forced to choose between their medicine and their home